Physician profile
Mark L Fallick
NPI 1245297837
$455.82
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $103 · 2021: $28.45 · 2023: $57.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $89.73 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $79.97 | 2019 | |
| Ferring Pharmaceuticals INC. | $57.65 | 2023 | Adstiladrin |
| Allergan, INC. | $39.62 | 2019 | |
| Astellas Pharma US INC | $38.44 | 2019 | |
| Janssen Biotech, INC. | $29.29 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $26.94 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.59 | 2019 | |
| Boston Scientific Corporation | $19.46 | 2019 | |
| Coloplast Corp | $17.04 | 2019 | |
| Dendreon Pharmaceuticals LLC | $12.15 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.57 | 2019 | |
| Pfizer INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Fallick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.